MedTrace Logo

The Jordan Study for End-Stage Renal Disease Subjects

NCT05382663 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2024-06-21

No results posted yet for this study

Summary

To compare the Alio device to blood draws.

Conditions

Interventions

DEVICE

Alio Device

Non-invasive device worn over vasculature.

Sponsors & Collaborators

  • Alio, Inc.

    lead INDUSTRY

Principal Investigators

  • Tawfiq Arafat, MD · Alkhansaa Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-21
Primary Completion
2024-11-01
Completion
2024-11-01
FDA Device
Yes

Countries

  • Jordan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05382663 on ClinicalTrials.gov